Global Freezing Pen Market Strategic Research Report

Scope of the Report

The global Freezing Pen market size is predicted to grow from US$ 254 million in 2025 to US$ 388 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.

Global freezing pen production in 2025 is 153,000 units, with an average price of US$1,600 per unit.

Freezing Pen, also known as Freeze Pen, is a medical device used in cryotherapy for the removal of benign skin lesions like warts, skin tags, and age spots. It works by delivering a precise, focused blast of extremely cold gas, typically nitrous oxide, to freeze and destroy the targeted tissue.

The upstream of freezing pens mainly includes suppliers of medical liquid nitrogen, medical nitrous oxide, precision metal nozzles and needles, medical valves and micro-gas circuit components, and medical device-grade housings and seals. Representative companies include Air Liquide, Praxair, Nippon Sanso, Swagelok, and Parker Hannifin. Downstream demand is primarily concentrated in dermatology chain hospitals, aesthetic medicine institutions, maternal and infant hospitals, dermatology prevention and treatment centers, and primary community health stations. Typical clients include Dermatology Specialists, SkinCeuticals Clinics, DermTech Clinics, Guosai Dermatology Medical, and Ruili Medical Aesthetics. Downstream demand centers on localized cryotherapy, covering warts, skin tags, pigmented lesions, vascular lesions, and the management of mild tumors, extending to minor aesthetic treatments. The rapid expansion of aesthetic medicine institutions in China, Southeast Asia, and Latin America has increased the demand for low-cost, easy-to-use cryotherapy pens.

Industry trends are characterized by rapid growth in demand for disposable freezing pens, the rise of portable devices to replace carbon dioxide or liquid nitrogen tanks, high-frequency consumption due to shorter procedures in aesthetic and minimally invasive medical treatments, exploratory penetration of home skin care devices, and the emergence of smart cryopens driven by increased compliance and traceability requirements. Driving factors include the expansion of the aesthetic medicine market, an increase in dermatology patients, expansion of primary healthcare facilities, a growing preference for lightweight treatments, and shorter repurchase cycles due to the disposable nature of equipment. Obstacles mainly include transportation and storage restrictions on liquid nitrogen and N₂O, price competition from low-end products, stricter regulations on aesthetic medicine in some countries, cost fluctuations of disposable cryotherapy agents, and the gradual replacement of some treatments by lasers.

The industry's annual production capacity for a single production line is typically between 150,000 and 300,000 units, with gross profit margins generally between 28% and 45%.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Freezing Pen market?

What factors are driving Freezing Pen market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Freezing Pen market opportunities vary by end market size?

How does Freezing Pen break out by Type, by Application?

This report presents a comprehensive overview of the global Freezing Pen market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Nitrous Oxide (N₂O) Cryo Pen
• Liquid Nitrogen (LN₂) Cryo Pen
• Carbon Dioxide (CO₂) Cryo Pen

Segment by Risk Level

• Class I
• Class II
• Class III

Segment by Cartridges

• 8g
• 16g

Segment by Application

• Dermatology
• Aesthetics
• Gynecology
• Podiatry
• Veterinary Medicine
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Freezing Pen market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Dermatology, Aesthetics, Gynecology evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact